英文名称
6-Desacetyl N-Oxide Palbociclib
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
6-Desacetyl N-Oxide Palbociclib is an impurity of Palbociclib (P139900),(also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.